Chemokines and chemokine receptors as therapeutic targets in lupus nephritis

被引：43
|
作者：
Vielhauer, Volker [1 ]
Anders, Hans-Joachim [1 ]
Schloendorff, Detlef [1 ]
机构：
[1] Klinikum Univ Munchen, Med Poliklin Innenstadt, Munich, Germany
来源：
SEMINARS IN NEPHROLOGY | 2007年 / 27卷 / 01期
关键词：
chemokine; chemokine receptors; systemic lupus erythematosus; MRL/lpr mouse; leukocyte recruitment; kidney; receptor antagonist; polymorphisms;
D O I：
10.1016/j.semnephrol.2006.09.010
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Recruitment of leukocytes is a characteristic feature of tissue injury in systemic lupus erythematosus, including lupus nephritis. Locally secreted chemokines and their receptors are important mediators of leukocyte recruitment to the specific sites of immune complex injury, and contribute to renal inflammatory disease in the initiation and progression phase. Therefore, chemokines and chemokine receptors represent potential therapeutic targets in lupus nephritis. In this review we summarize available experimental and human data supporting their functional role in lupus nephritis. Moreover, interventional studies with chemokine and chemokine receptor antagonists that show the therapeutic potential of chemokine antagonists in experimental models of lupus nephritis and potentially in human renal disease are discussed. © 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码：81 / 97
页数：17
相关论文
共 50 条
  • [21] Chemokines and chemokine receptors in scleroderma
    Yamamoto, Toshiyuki
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2006, 140 (04) : 345 - 356
  • [22] Chemokines and chemokine receptors: an overview
    Bonecchi, Raffaella
    Galliera, Emanuela
    Borroni, Elena M.
    Corsi, Massimiliano M.
    Locati, Massimo
    Mantovani, Alberto
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 540 - 551
  • [23] Chemokines, chemokine receptors and pain
    Abbadie, C
    [J]. TRENDS IN IMMUNOLOGY, 2005, 26 (10) : 529 - 534
  • [24] Atypical chemokine receptors: emerging therapeutic targets in cancer
    Torphy, Robert J.
    Yee, Elliott J.
    Schulick, Richard D.
    Zhu, Yuwen
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (12) : 1085 - 1097
  • [25] Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges
    Sadeghian-Rizi, Tahereh
    Khanahmad, Hossein
    Jahanian-Najafabadi, Ali
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2018, 17 (07) : 496 - 508
  • [26] Monocyte chemokine receptors as therapeutic targets in cardiovascular diseases
    Germano, Danielle Borges
    Oliveira, Steffany Bernardo
    Bachi, Andre Luis Lacerda
    Juliano, Yara
    Novo, Neil Ferreira
    do Amaral, Jonatas Bussador
    Franca, Carolina Nunes
    [J]. IMMUNOLOGY LETTERS, 2023, 256 : 1 - 8
  • [27] Chemokines, chemokine receptors and atherosclerosis
    John, AE
    Channon, KM
    Greaves, DR
    [J]. CHEMOKINES, CHEMOKINE RECEPTORS, AND DISEASE, 2005, 55 : 223 - 253
  • [28] Chemokines and Chemokine Receptors as Novel Therapeutic Targets in Rheumatoid Arthritis (RA): Inhibitory Effects of Traditional Chinese Medicinal Components
    Chen, Xin
    Oppenheim, Joost J.
    Howard, O. M. Zack
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2004, 1 (05) : 336 - 342
  • [29] Chemokines and their receptors as potential therapeutic targets for allergic diseases.
    Matsushima, K
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 17P - 17P
  • [30] Chemokines and Chemokine Receptors as Novel Therapeutic Targets in Rheumatoid Arthritis (RA):Inhibitory Effects of Traditional Chinese Medicinal Components
    Joost J.Oppenheim
    O.M.Zack Howard
    [J]. Cellular & Molecular Immunology, 2004, (05) : 336 - 342
12345